Docosatetraenoylethanolamide
Docosatetraenoylethanolamide (DEA) is an endogenous ethanolamide that has been shown to act on the cannabinoid (CB1) receptor. DEA is similar in structure to anandamide (AEA, a recognized endogenous ligand for the CB1 receptor), containing docosatetraenoic acid in place of arachidonic acid. While DEA has been shown to bind to the CB1 receptor with similar potency and efficacy as AEA, its role as a cannabinergic neurotransmitter is not well understood.
Wikipage disambiguates
primaryTopic
Docosatetraenoylethanolamide
Docosatetraenoylethanolamide (DEA) is an endogenous ethanolamide that has been shown to act on the cannabinoid (CB1) receptor. DEA is similar in structure to anandamide (AEA, a recognized endogenous ligand for the CB1 receptor), containing docosatetraenoic acid in place of arachidonic acid. While DEA has been shown to bind to the CB1 receptor with similar potency and efficacy as AEA, its role as a cannabinergic neurotransmitter is not well understood.
has abstract
Docosatetraenoylethanolamide ( ...... mitter is not well understood.
@en
IUPAC name
(7Z,10Z,13Z,16Z)-N-(2-hydroxyethyl)docosa-7,10,13,16-tetraenamide
@en
Wikipage page ID
22,884,190
Wikipage revision ID
729,295,755
imagesize
Verifiedfields
verifiedrevid
460,960,124
hypernym
comment
Docosatetraenoylethanolamide ( ...... mitter is not well understood.
@en
label
Docosatetraenoylethanolamide
@en
